Lipella Pharmaceuticals Inc.
- Home
- Companies
- Lipella Pharmaceuticals Inc.
- News
- Announcing Radiation (and Hemorrhagic) ...
Announcing Radiation (and Hemorrhagic) Cystitis Patient Registry: for people affected by pelvic radiation during cancer treatment.
May. 9, 2022
Courtesy ofLipella Pharmaceuticals Inc.
Pittsburgh, PA – (May 9, 2022) – Lipella Pharmaceuticals, Inc. is announcing the Radiation Cystitis Patient Registry, an on-line patient registry program for people who are affected by pelvic radiation exposure, including survivors of pelvic cancers, such as prostate, uterine, cervical and colon cancer.
